| III-43 Koen Jolling CHF5993 a triple combination therapy for COPD patients: population pharmacokinetic modelling of beclometasone-17-monopropionate (B17MP) following pMDI inhalation. Thursday 09:50-11:20 |
| III-43 Koen Jolling CHF5993 a triple combination therapy for COPD patients: population pharmacokinetic modelling of beclometasone-17-monopropionate (B17MP) following pMDI inhalation. Thursday 09:50-11:20 |